Coupling of folding and binding in the PTB domain of the signaling protein Shc

Structure

Volumn 11, Issue 8, 2003, Pages 905-913

  Farooq, Amjad ^a   Zeng, Lei ^a   Yan, Kelley S ^a   Ravichandran, Kodi S ^b   Zhou, Ming Ming ^a  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PHOSPHOPEPTIDE; PROTEIN SHC;

ARTICLE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE;

EID: 0042632778     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(03)00134-5     Document Type: Article

References (50)

1. Batzer A.G., Rotin D., Urena J.M., Skolnik E.Y., Schlessinger J. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol. Cell. Biol. 14:1994;5192-5201.
2. Batzer A.G., Blaikie P., Nelson K., Schlessinger J., Margolis B. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol. Cell. Biol. 15:1995;4403-4409.
3. Blaikie P., Immanuel D., Wu J., Li N., Yajnik V., Margolis B. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J. Biol. Chem. 269:1994;32031-32034.
4. Borrello M.G., Pelicci G., Arighi E., Filippis L.D., Greco A., Bongarzone I., Rizzetti M.G., Pelicci P.G., Pierotti M.A. The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. Oncogene. 9:1994;1661-1668.
5. Brunger A.T. X-PLOR Version 3.1. A System for X-Ray Crystallography and NMR:1993;Yale University Press, New Haven, CT.
6. Clore G.M., Gronenborn A.M. Multidimensional heteronuclear nuclear magnetic resonance of proteins. Methods Enzymol. 239:1994;349-363.
7. Cornilescu G., Delaglio F., Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR. 13:1999;289-302.
8. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe. a multidimensional spectral processing system based on UNIX pipes J. Biomol. NMR. 6:1995;277-293.
9. Dhalluin C., Yan K.S., Plotnikova O., Lee K.W., Zeng L., Kuti K., Mujtaba S., Goldfarb M.P., Zhou M.-M. Structural basis of SNT PTB domain interactions with distinct neurotrophic receptors. Mol. Cell. 6:2000;921-929.
10. Dilworth S.M., Brewster C.E.P., Jones M.D., Lanfrancone L., Pelicci G., Pelicci P.G. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature. 367:1994;87-90.
11. Dunker A.K., Lawson J.D., Brown C.J., Williams R.M., Romero P., Oh J.S., Oldfield C.J., Campen A.M., Ratliff C.M., Hipps K.W.et al. Intrinsically disordered protein. J. Mol. Graph. Model. 19:2001;26-59.
12. Dyson H.J., Wright P.E. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12:2002;54-60.
13. Eck M.J., Dhe-Paganon S., Trüb T., Nolte R., Shoelson S.E. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell. 85:1996;695-705.
14. Farooq A., Plotnikova O., Zeng L., Zhou M.-M. Phosphotyrosine binding domains of Shc and IRS1 recognize the NPXpY motif in a thermodynamically distinct manner. J. Biol. Chem. 274:1999;6114-6121.
15. Goga A., McLaughlin J., Afar D.E., Saffran D.C., Witte O.N. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell. 82:1995;981-988.
16. Graham T.A., Weaver C., Mao F., Kimelman D., Xu W. Crystal structure of a β-catenin/Tcf complex. Cell. 103:2000;885-896.
17. Habib T., Herrera R., Decker S.J. Activators of protein kinase C stimulate association of Shc and the PEST tyrosine phosphatase. J. Biol. Chem. 269:1994;25243-25246.
18. He X.-L., Chow D.-C., Martick M.M., Garcia K.C. Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone. Science. 293:2001;1657-1662.
19. Huber A.H., Weis W.I. The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell. 105:2001;391-402.
20. Johnson B.A., Blevins R.A. NMRView. a computer program for the visualization and analysis of NMR data J. Biomol. NMR. 4:1994;603-614.
21. Kavanaugh W.M., Williams L.T. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science. 266:1994;1862-1865.
22. Kim A.S., Kakalis L.T., Abdul-Manan N., Liu G.A., Rosen M.K. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature. 404:2000;151-158.
23. Kremer N.E., D'Arcangelo G., Thomas S.M., DeMarco M., Brugge J.S., Halegoua S. Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of src and ras actions. J. Cell Biol. 115:1991;809-819.
24. Kumar S., Ma B., Tsai C.J., Sinha N., Nussinov R. Folding and binding cascades. dynamic landscapes and population shifts Protein Sci. 9:2000;10-19.
25. Laminet A.A., Apell G., Conroy L., Kavanaugh W.M. Affinity, specificity, and kinetics of the interaction of the Shc PTB domain with NPXpY motifs of growth factor receptors. J. Biol. Chem. 271:1996;264-269.
26. Lei M., Lu W., Meng W., Parrini M.C., Eck M.J., Mayer B.J., Harrison S.C. Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell. 102:2000;387-397.
27. Li S.-C., Zwahlen C., Vincent S.J., McGlade C.J., Kay L.E., Pawson T., Forman-Kay J.D. Structure of a Numb PTB domain-peptide complex suggests a basis for diverse binding specificity. Nat. Struct. Biol. 5:1998;1075-1083.
28. Logan T.M., Olejniczak E.T., Xu R.X., Fesik S.W. A general method for assigning NMR spectra of denatured proteins using 3D HC(CO)NH-TOCSY triple resonance experiments. J Biomol NMR. 3:1993;225-231.
29. Ma B., Kumar S., Tsai C.-J., Nussinov R. Folding funnels and binding mechanisms. Protein Eng. 12:1999;713-720.
30. Nilges M., O'Donoghue S. Ambiguous NOEs and automated NOE assignment. Prog. NMR Spectrosc. 32:1998;107-139.
31. Obermeier A., Lammers R., Weismuller K., Schlessinger J., Ullrich A. Identification of Trk binding sites for Shc and phosphatidylinositol 3′-kinase and formation of a multimeric signaling complex. J. Biol. Chem. 268:1993;22963-22966.
32. Obermeier A., Bradshaw R.A., Seedorf K., Choidas A., Schlessinger J., Ullrich A. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk bindings for Shc and PLCg. EMBO J. 13:1994;1585-1590.
33. Okada S., Yamauchi K., Pessin J.E. Shc isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors. J. Biol. Chem. 270:1995;20737-20741.
34. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grignani F., Pawson T. A novel transforming protein (Shc) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 70:1992;93-104.
35. Pelicci G., Lanfrancone L., Salcini A.E., Romano A., Mele S., Borrello M.G., Segatto O., Fiore P.P.D., Pelicci P.G. Constitutive phosphorylation of Shc proteins in human tumors. Oncogene. 11:1995;899-907.
36. Ricci A., Lanfrancone L., Chiari R., Belardo G., Pertica C., Natali P.G., Pelicci P.G., Segatto O. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the erbB-2 kinase. Oncogene. 11:1995;1519-1529.
37. Rozakis-Adcock M., McGlade J., Mbamalu G., Pelicci G., Daly R., Li W., Batzer A., Thoma S., Brugge J., Pelicci P.G.et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the ras pathway by tyrosine kinases. Nature. 360:1992;689-692.
38. Salcini A., McGlade J., Pelicci G., Nicoletti I., Pawson T., Pelicci P. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene. 9:1994;2827-2836.
39. Sattler M., Schleucher J., Griesinger C. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog. NMR Spectrosc. 34:1999;93-158.
40. Stevenson L.E., Frackelton A.R.J. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells. correlation with ErbB2 and p66 Shc expression Breast Cancer Res. Treat. 49:1998;119-128.
41. Stolt P.C., Jeon H., Song H.K., Herz J., Eck M.J., Blacklow S.C. Origins of peptide selectivity and phosphoinositide binding revealed by structures of Disabled-1 PTB domain complexes. Structure. 11:2003;569-579.
42. Tsai C.-J., Ma B., Nussinov R. Folding and binding cascades. shifts in energy landscapes Proc. Natl. Acad. Sci. USA. 96:1999;9970-9972.
43. van der Geer P., Wiley S., Lai V.K.-M., Olivier J.P., Gish G.D., Stephens R., Kaplan D., Shoelson S., Pawson T. A conserved amino-terminal Shc domain binds to activated growth factor receptors and phosphotyrosine-containing peptides. Curr. Biol. 5:1995;404-412.
44. 2H labeled proteins with high sensitivity. J. Am. Chem. Soc. 116:1994;11655-11666.
45. Yokote K., Mori S., Hansen K., McGlade J., Pawson T., Heldin C.-H., Claesson-Welsh L. Direct interaction between Shc and the platelet-derived growth factor β-receptor. J. Biol. Chem. 269:1994;15337-15343.
46. Zhang Z., Lee C.-H., Mandiyan V., Borg J.-P., Margolis B., Schlessinger J., Kuriyan J. Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain. EMBO J. 16:1997;6141-6150.
47. 2-terminal phosphotyrosine binding domain of Shc. J. Biol. Chem. 270:1995;31119-31123. a.
48. Zhou M.-M., Ravichandran K.S., Olejniczak E.T., Petros A.P., Meadows R.P., Sattler M., Harlan J.E., Wade W., Burakoff S.J., Fesik S.W. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature. 378:1995;584-592. b.
49. Zhou M.-M., Huang B., Olejniczak E.T., Meadows R.P., Shuker S.B., Miyazak M., Trüb T., Shoelson S.E., Fesik S.W. Structural basis of IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat. Struct. Biol. 3:1996;388-393.
50. Zwahlen C., Li S.-C., Kay L.E., Pawson T., Forman-Kay J.D. Multiple modes of peptide recognition by the PTB domain of the cell fate determinant Numb. EMBO J. 19:2000;1505-1515.